High Dose SBRT for Abdominal-Pelvic Lymph Nodal Lesions in Oligometastatic Patients

ABSTRACT: This is a prospective, multicentric, phase II and feasibility study aimed to address early and late side effects of hypofractionated ablative radiotherapy for oligometastatic patients with lymph node metastases for genito-urinary, gastro-intestinal and gynaecological cancer.

DISEASE(S): Lymph Node Cancer Metastatic

PROVIDER: 2199687 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR